Newsroom

Sorted by: Latest
-

Range Adds Apex Fintech Solutions to Power Next Phase of Growth

NEW YORK--(BUSINESS WIRE)--Apex Fintech Solutions Inc. (“Apex”), the infrastructure powering modern investing, and Range Finance, a financial platform built for high-income households, today announced a strategic alliance to power Range's next phase of growth. Through this collaboration, Range will leverage Apex's cloud-native AscendOS™ platform to deliver an enhanced wealth management experience for its members, including self-directed account openings and transfers, while laying the foundation...
-

 Evolv Express® Selected to Support Security Operations at Climate Pledge Arena

WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company, today announced that the company has been selected as the new security screening provider at Climate Pledge Arena, one of North America’s busiest sports and entertainment venues. Climate Pledge Arena selected Evolv Express® people screening systems to help enhance the arrival experience for millions of guests attending games, concerts, and other live events. Climate Pledge A...
-

American Express is Now Accepted at More Than 190 Million Merchant Locations Worldwide; Acceptance Outside the U.S. Has More Than Doubled in Last Four Years

NEW YORK--(BUSINESS WIRE)--American Express today announced that its Cards are now accepted at more than 190 million Merchant locations worldwide1, an increase of approximately 20 million locations this year. The number of Amex-accepting Merchant locations outside the U.S. has more than doubled over the last four years. This growth reflects ongoing momentum in the company's global acceptance strategy, driven by key partnerships, targeted expansion in the places Card Members live, work, and trav...
-

U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related to Breast Cancer

WHIPPANY, N.J.--(BUSINESS WIRE)--Today Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) and granted Priority Review designation for Lynkuet® (elinzanetant) under investigation for the treatment of moderate to severe vasomotor symptoms (VMS, also known as hot flashes) in women receiving endocrine therapy for treatment of breast cancer. First approved by the FDA in October 2025 for the treatment of moderate to sev...
-

Circle Pharma Strengthens Leadership Team with Promotion of Marie Evangelista, Ph.D., to Chief Scientific Officer and Addition of Mary Ellen Sillivos as SVP and Head of Human Resources

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced the promotion of Marie Evangelista, Ph.D., to chief scientific officer and the appointment of Mary Ellen Sillivos as senior vice president and head of human resources. The appointments strengthen Circle’s leadership team as the company advances its pipeline of next-generation targeted macrocycle ther...
-

H.B. Fuller Appoints R. Jeffrey Bailly to Board of Directors

ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL), the world’s largest pureplay adhesives company, today announced the appointment of R. Jeffrey Bailly to its Board of Directors, effective immediately. In connection with this appointment, Ruth Kimmelshue will be stepping down from the Board. “Jeff brings highly relevant operating and leadership experience across key medical end markets as we focus on accelerating our path to greater than 20% adju...
-

Salient Motion Launches Saginaw Precision to Manufacture Precision Ball Screws, a Critical Link in the Missile and Robotics Supply Chain

HAWTHORNE, Calif. & SAGINAW, Mich.--(BUSINESS WIRE)--Salient Motion today announced the launch of Saginaw Precision, a new division focused on precision ball screws and roller screws for aerospace, defense, robotics, and other high-performance actuation applications. Missiles rely on electromechanical actuators to precisely position their fins and control their flight. At the heart of each actuator is a high-precision ball screw, manufactured to tolerances measured in fractions of the width of...
-

Tolerance Bio Licenses Clinical-Stage Anti-IL-33 Monoclonal Antibody from Tanabe Pharma to Expand Thymus-Focused Clinical Pipeline

PHILADELPHIA--(BUSINESS WIRE)--Tolerance Bio Licenses Clinical-Stage Anti-IL-33 Monoclonal Antibody from Tanabe Pharma to Expand Thymus-Focused Clinical Pipeline...
-

Aurora Networks and Ziggo Achieve Europe’s First Large-scale Deployment of Unified DOCSIS 4.0 Nodes in a Live Network

RICHARDSON, Texas--(BUSINESS WIRE)--Vistance Networks (NASDAQ: VISN) today announced Europe’s first large-scale deployment of Unified DOCSIS 4.0 nodes in a live network....
-

Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Tempus ECG-MR, an AI product that analyzes standard 12-lead resting electrocardiograms (ECGs) to detect signs associated with undiagnosed moderate or severe mitral regurgitation (MR). MR is a common form of heart valve disease where blood leaks backward through the mitral valve. Because early stages are often asymptomatic or manifest as no...